↓ Skip to main content

Dove Medical Press

Article Metrics

Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#28 of 1,192)
  • High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news
5 news outlets
blogs
1 blog

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
77 Mendeley
Title
<p>Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care</p>
Published in
Therapeutics and Clinical Risk Management, February 2020
DOI 10.2147/tcrm.s219979
Pubmed ID
Authors

Marco Luigetti, Angela Romano, Andrea Di Paolantonio, Giulia Bisogni, Mario Sabatelli

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Other 17 22%
Student > Bachelor 10 13%
Researcher 6 8%
Student > Master 6 8%
Student > Doctoral Student 3 4%
Other 11 14%
Unknown 24 31%
Readers by discipline Count As %
Medicine and Dentistry 17 22%
Pharmacology, Toxicology and Pharmaceutical Science 9 12%
Biochemistry, Genetics and Molecular Biology 5 6%
Nursing and Health Professions 3 4%
Engineering 3 4%
Other 11 14%
Unknown 29 38%

Attention Score in Context

This research output has an Altmetric Attention Score of 45. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2021.
All research outputs
#690,386
of 20,578,028 outputs
Outputs from Therapeutics and Clinical Risk Management
#28
of 1,192 outputs
Outputs of similar age
#16,681
of 340,627 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 3 outputs
Altmetric has tracked 20,578,028 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,192 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,627 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them